204 related articles for article (PubMed ID: 32571464)
1. [Expression and diagnostic value of plasma miR-145 and miR-183 in children with lupus nephritis].
Lin LJ; Mai LJ; Chen G; Zhao EN; Xue M; Su XD
Zhongguo Dang Dai Er Ke Za Zhi; 2020 Jun; 22(6):632-637. PubMed ID: 32571464
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of miR-200a in systemic lupus erythematosus and renal damage in children.
Zhang H; Zhou X; Li Q; Zheng M
Cell Mol Biol (Noisy-le-grand); 2024 Jan; 70(1):94-98. PubMed ID: 38372106
[TBL] [Abstract][Full Text] [Related]
3. Serum uric acid as a predictor for nephritis in Egyptian patients with systemic lupus erythematosus.
Hafez EA; Hassan SAE; Teama MAM; Badr FM
Lupus; 2021 Mar; 30(3):378-384. PubMed ID: 33323012
[TBL] [Abstract][Full Text] [Related]
4. Using plasma circRNA_002453 as a novel biomarker in the diagnosis of lupus nephritis.
Ouyang Q; Huang Q; Jiang Z; Zhao J; Shi GP; Yang M
Mol Immunol; 2018 Sep; 101():531-538. PubMed ID: 30172209
[TBL] [Abstract][Full Text] [Related]
5. Do classic blood biomarkers of JSLE identify active lupus nephritis? Evidence from the UK JSLE Cohort Study.
Smith EMD; Jorgensen AL; Beresford MW;
Lupus; 2017 Oct; 26(11):1212-1217. PubMed ID: 28385126
[TBL] [Abstract][Full Text] [Related]
6. Relationship of cell-free urine MicroRNA with lupus nephritis in children.
Abulaban KM; Fall N; Nunna R; Ying J; Devarajan P; Grom A; Bennett M; Ardoin SP; Brunner HI
Pediatr Rheumatol Online J; 2016 Jan; 14(1):4. PubMed ID: 26762103
[TBL] [Abstract][Full Text] [Related]
7. Serum human epididymis protein 4 is a predictor for developing nephritis in patients with systemic lupus erythematosus: A prospective cohort study.
Ren Y; Xie J; Lin F; Luo W; Zhang Z; Mao P; Zhong R; Liang Y; Yang Z
Int Immunopharmacol; 2018 Jul; 60():189-193. PubMed ID: 29747124
[TBL] [Abstract][Full Text] [Related]
8. Serum beta-2 microglobulin as a predictor of nephritis, disease activity, and damage score in systemic lupus erythematosus: a cross-sectional study.
Gamal DM; Badr FM; Taha SIAEF; Moustafa NM; Teama MAEM
Rheumatol Int; 2023 Feb; 43(2):323-333. PubMed ID: 36205758
[TBL] [Abstract][Full Text] [Related]
9. Serum miRNA-21, miRNA-146a and plasma cell free DNA as novel biomarkers for assessing systemic lupus erythematosus activity.
Ibrahim MRK; Waly NG; Moness H; Ahmed SS; Ibrahem R
Mol Biol Rep; 2023 Dec; 50(12):10025-10036. PubMed ID: 37904010
[TBL] [Abstract][Full Text] [Related]
10. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY
Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of progranulin in patients with lupus nephritis and its correlation with disease activity.
Wu J; Wei L; Wang W; Zhang X; Chen L; Lin C
Rheumatol Int; 2016 Jun; 36(6):759-67. PubMed ID: 26968845
[TBL] [Abstract][Full Text] [Related]
12. Value of sTNF-R1 and linc0597 as indicators for disease activity and diagnosis of lupus nephritis.
Zheng CZ; Yan WW; Luo YL; Wang TL; Shu YB
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5582-5591. PubMed ID: 32495893
[TBL] [Abstract][Full Text] [Related]
13. Urinary C3d is elevated in patients with active Lupus nephritis and a fall in its level after 3 months predicts response at 6 months on follow up.
Ganguly S; Majumder S; Kumar S; Gupta R; Muhammed H; Shobha V; Aggarwal A; Misra R
Lupus; 2020 Nov; 29(13):1800-1806. PubMed ID: 32807020
[TBL] [Abstract][Full Text] [Related]
14. Low complements and high titre of anti-Sm antibody as predictors of histopathologically proven silent lupus nephritis without abnormal urinalysis in patients with systemic lupus erythematosus.
Ishizaki J; Saito K; Nawata M; Mizuno Y; Tokunaga M; Sawamukai N; Tamura M; Hirata S; Yamaoka K; Hasegawa H; Tanaka Y
Rheumatology (Oxford); 2015 Mar; 54(3):405-12. PubMed ID: 25183834
[TBL] [Abstract][Full Text] [Related]
15. Do circulating antibodies against C1q reflect the activity of lupus nephritis?
Smykał-Jankowiak K; Niemir ZI; Polcyn-Adamczak M
Pol Arch Med Wewn; 2011 Sep; 121(9):287-95. PubMed ID: 21860370
[TBL] [Abstract][Full Text] [Related]
16. Clinico-pathological associations of serum VCAM-1 and ICAM-1 levels in patients with lupus nephritis.
Yu KY; Yung S; Chau MK; Tang CS; Yap DY; Tang AH; Ying SK; Lee CK; Chan TM
Lupus; 2021 Jun; 30(7):1039-1050. PubMed ID: 33765901
[TBL] [Abstract][Full Text] [Related]
17. Anti-C1q antibodies in lupus nephritis children with glomerular microthrombosis.
Zhang P; Yang X; Fang X; Xu C; Gao C; Xia Z
Nephrology (Carlton); 2023 Sep; 28(9):485-494. PubMed ID: 37485575
[TBL] [Abstract][Full Text] [Related]
18. The correlation of plasma microRNA-200 family expressions with risk and disease severity of lupus nephritis.
Zhang Y; Wang Y
Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3118-3125. PubMed ID: 29863256
[TBL] [Abstract][Full Text] [Related]
19. Circulating miR-181a and miR-223 expression with the potential value of biomarkers for the diagnosis of systemic lupus erythematosus and predicting lupus nephritis.
Abdul-Maksoud RS; Rashad NM; Elsayed WSH; Ali MA; Kamal NM; Zidan HE
J Gene Med; 2021 May; 23(5):e3326. PubMed ID: 33617143
[TBL] [Abstract][Full Text] [Related]
20. [Feasibility of SLEDAI-2000 and BILAG-2004 scoring systems for assessing renal disease activity in children with lupus nephritis].
Zhou JQ; Jiang H
Zhongguo Dang Dai Er Ke Za Zhi; 2012 Oct; 14(10):775-9. PubMed ID: 23092572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
